Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The SOUND Trial
NCT07281508Phase 3Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Aug 2025
- Primary completion
- Mar 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium thiosulfate in hearing loss, sponsored by Netherlands Cancer Institute. Started Aug 2025; status: recruiting.
02
Drugs
sodium thiosulfate
03
Conditions
hearing loss
Beyond the preview
Go deeper on NCT07281508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07281508.